[1]
“PROM2 decreases cisplatin sensitivity in non-small cell lung cancer and is regulated by CTCF”, Radiol Oncol, vol. 57, no. 3, pp. 325–336, Sep. 2023, Accessed: Sep. 23, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/4013